- Home
- CBRL vs EVO Comparison
CBRL vs EVO Comparison
Compare CBRL & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRL
- EVO
- Stock Information
- Founded
- CBRL 1969
- EVO 1993
- Country
- CBRL United States
- EVO Germany
- Employees
- CBRL N/A
- EVO N/A
- Industry
- CBRL Restaurants
- EVO Biotechnology: Pharmaceutical Preparations
- Sector
- CBRL Consumer Discretionary
- EVO Health Care
- Exchange
- CBRL Nasdaq
- EVO Nasdaq
- Market Cap
- CBRL 1.2B
- EVO 1.4B
- IPO Year
- CBRL N/A
- EVO 2021
- Fundamental
- Price
- CBRL $59.21
- EVO $3.82
- Analyst Decision
- CBRL Hold
- EVO Buy
- Analyst Count
- CBRL 8
- EVO 2
- Target Price
- CBRL $53.86
- EVO $5.90
- AVG Volume (30 Days)
- CBRL 1.2M
- EVO 159.1K
- Earning Date
- CBRL 06-05-2025
- EVO 08-13-2025
- Dividend Yield
- CBRL 1.69%
- EVO N/A
- EPS Growth
- CBRL N/A
- EVO N/A
- EPS
- CBRL 2.58
- EVO N/A
- Revenue
- CBRL $3,510,062,000.00
- EVO $851,944,444.00
- Revenue This Year
- CBRL $1.88
- EVO $10.08
- Revenue Next Year
- CBRL $1.81
- EVO $10.99
- P/E Ratio
- CBRL $22.89
- EVO N/A
- Revenue Growth
- CBRL 2.84
- EVO 1.50
- 52 Week Low
- CBRL $33.86
- EVO $2.84
- 52 Week High
- CBRL $65.43
- EVO $5.64
- Technical
- Relative Strength Index (RSI)
- CBRL 56.84
- EVO 44.08
- Support Level
- CBRL $51.95
- EVO $4.06
- Resistance Level
- CBRL $60.68
- EVO $4.44
- Average True Range (ATR)
- CBRL 3.31
- EVO 0.10
- MACD
- CBRL -0.17
- EVO -0.03
- Stochastic Oscillator
- CBRL 71.16
- EVO 5.83
About CBRL Cracker Barrel Old Country Store Inc
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The restaurants of the company are open for breakfast, lunch, and dinner, with menus that offer home-style country food. The company generates maximum revenue from the Restaurants.
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.